MedPath

The effect of glucose added to dialysis fluid on blood pressure, blood glucose and quality of life in hemodialysis patients. A placebo controlled cross-over study

Completed
Conditions
Chronic renal failure
Nutritional, Metabolic, Endocrine
Registration Number
ISRCTN53978980
Lead Sponsor
Holstebro Hospital (Denmark)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
60
Inclusion Criteria

Age more than 18 years, both men and women, and hemodialysis treatment for more than three months

Exclusion Criteria

1. Treatment with hemodiafiltration
2. Change to another dialysis modality
3. Renal transplantation
4. Alcohol abuse defined as more than 21 units a week for men and more than fourteen units a week for women
5. Unwillingness to participate

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath